Literature DB >> 26515047

A Bradyzoite is a Bradyzoite is a Bradyzoite?

Kami Kim1.   

Abstract

Bradyzoite forms of Toxoplasma gondii persist in tissue cysts for the lifetime of an infected host and can reactivate to cause clinical disease. It was thought that in vivo bradyzoites within tissue cysts are biologically inactive dormant forms that rarely replicate. Apparently, consensus was wrong.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Toxoplasma; bradyzoite; tissue cyst

Mesh:

Year:  2015        PMID: 26515047      PMCID: PMC4679416          DOI: 10.1016/j.pt.2015.10.005

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  10 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

Review 2.  Cytoskeleton assembly in Toxoplasma gondii cell division.

Authors:  Brooke Anderson-White; Josh R Beck; Chun-Ti Chen; Markus Meissner; Peter J Bradley; Marc-Jan Gubbels
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts.

Authors:  V B Carruthers; L D Sibley
Journal:  Eur J Cell Biol       Date:  1997-06       Impact factor: 4.492

Review 4.  Toxoplasma's ways of manipulating the host transcriptome via secreted effectors.

Authors:  Mohamed-Ali Hakimi; Alexandre Bougdour
Journal:  Curr Opin Microbiol       Date:  2015-04-24       Impact factor: 7.934

5.  Separation of Isospora (Toxoplasma) gondii cysts and cystozoites from mouse brain tissue by continuous density-gradient centrifugation.

Authors:  A W Cornelissen; J P Overdulve; J M Hoenderboom
Journal:  Parasitology       Date:  1981-08       Impact factor: 3.234

6.  Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis.

Authors:  J Stone Doggett; Aaron Nilsen; Isaac Forquer; Keith W Wegmann; Lorraine Jones-Brando; Robert H Yolken; Claudia Bordón; Susan A Charman; Kasiram Katneni; Tracey Schultz; Jeremy N Burrows; David J Hinrichs; Brigitte Meunier; Vern B Carruthers; Michael K Riscoe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

7.  Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Authors:  Yasuhiro Suzuki; Xisheng Wang; Benard S Jortner; Laura Payne; Yanyan Ni; Sara A Michie; Baohui Xu; Tomoya Kudo; Sara Perkins
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

8.  The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence.

Authors:  Tadakimi Tomita; David J Bzik; Yan Fen Ma; Barbara A Fox; Lye Meng Markillie; Ronald C Taylor; Kami Kim; Louis M Weiss
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

9.  Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo.

Authors:  Elizabeth Watts; Yihua Zhao; Animesh Dhara; Becca Eller; Abhijit Patwardhan; Anthony P Sinai
Journal:  MBio       Date:  2015-09-08       Impact factor: 7.867

10.  Chitinase dependent control of protozoan cyst burden in the brain.

Authors:  J Philip Nance; Kevin M Vannella; Danielle Worth; Clément David; David Carter; Shahani Noor; Cedric Hubeau; Lori Fitz; Thomas E Lane; Thomas A Wynn; Emma H Wilson
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

  10 in total
  4 in total

1.  Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design.

Authors:  Matthew E Welsch; Jian Zhou; Yueqiang Gao; Yunqing Yan; Gene Porter; Gautam Agnihotri; Yingjie Li; Henry Lu; Zhongguo Chen; Stephen B Thomas
Journal:  ACS Med Chem Lett       Date:  2016-09-17       Impact factor: 4.345

2.  Activation of chronic toxoplasmosis by transportation stress in a mouse model.

Authors:  Bang Shen; Yuan Yuan; Jianxi Cheng; Ming Pan; Ningbo Xia; Weichao Zhang; Yifan Wang; Yanqin Zhou; Junlong Zhao
Journal:  Oncotarget       Date:  2016-12-27

Review 3.  Drugs in development for toxoplasmosis: advances, challenges, and current status.

Authors:  P Holland Alday; Joseph Stone Doggett
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

4.  Chronic toxoplasmosis and sleepiness in obstructive sleep apnea: Is there a link?

Authors:  Céline Dard; Sébastien Bailly; Jean-Louis Pépin; Marie-Pierre Brenier-Pinchart; Hélène Fricker-Hidalgo; Marie Peeters; Hervé Pelloux; Renaud Tamisier
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.